Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?

The coronavirus disease 2019 (COVID-19) is the largest public health emergency in recent times. A significant number of patients develop a severe form of COVID-19 characterized by coagulopathy, organ failure, and elevated mortality. In addition, an unusually high frequency of antiphospholipid antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo-Martínez, Diana, Torres, Zaira, Amezcua-Guerra, Luis M., Pineda, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Perspectives in Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024929/
https://www.ncbi.nlm.nih.gov/pubmed/33826045
http://dx.doi.org/10.1007/s10067-021-05724-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024929/
https://www.ncbi.nlm.nih.gov/pubmed/33826045
http://dx.doi.org/10.1007/s10067-021-05724-5

Ejemplares similares